Clinical Trial Update: Branched-chain Amino Acid (BCAA) on Progression of Advanced Liver Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating branched-chain amino acids for progression of liver cirrhosis. The current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis

Drugs mentioned

• branched-chain amino acids (branched-chain amino acids)

Snippet

Sponsor: Kyungpook National University Hospital | Conditions: Liver Cirrhosis | Phase 4 | Status: UNKNOWN